Reply to “Are There Reasons To Prefer Tetracyclines to Macrolides in Older Patients with Community-Acquired Pneumonia?”

  • Kevin A. Brown, Nagham Khanafer, Nick Daneman, David N. Fisman
  • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals
  • DOI: 10.1128/aac.00864-13

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1128/aac.00864-13

The following have contributed to this page: nagham khanafer

In partnership with: